Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

Press releases published on November 9, 2026

Nov. 9, 2026

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Kraig Labs Ships Spider Silk to Developers Across Global Industries

Indeterminate GlobeNewswire

Nov. 9, 2026

Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Indeterminate GlobeNewswire

Nov. 9, 2026

Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients

Indeterminate GlobeNewswire

Nov. 9, 2026

USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows

Indeterminate GlobeNewswire

Nov. 9, 2026

CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina

Indeterminate GlobeNewswire

Nov. 9, 2026

Daré Bioscience Releases Next Episode in “CEO Corner” Video Series

Indeterminate GlobeNewswire

Nov. 9, 2026

NorthSea Therapeutics Announces Positive Phase 2 Topline Data in First-ever Randomized Placebo-controlled Study of an Oral Therapy in Intestinal Failure-Associated Liver Disease

Indeterminate GlobeNewswire

Nov. 9, 2026

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Expands Fermentation Capacity in León, Spain

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia baut Fermentationskapazitäten am Standort León in Spanien aus

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia amplía su capacidad de fermentación en León, España

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia augmente sa capacité de fermentation à León, en Espagne

Indeterminate GlobeNewswire

Nov. 9, 2026

קוריה מרחיבה את כושר התסיסה שלה בלאון, ספרד

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Memperluas Kapasitas Fermentasi di León, Spanyol

Indeterminate GlobeNewswire

Nov. 9, 2026

キュリア、スペイン・レオンで発酵能力を拡大

Indeterminate GlobeNewswire

Nov. 9, 2026

큐리아 (Curia), 스페인 레온 사업장 발효 생산능력 확대

Indeterminate GlobeNewswire